Ingrid S. Zeelenberg

1.8k total citations
19 papers, 1.5k citations indexed

About

Ingrid S. Zeelenberg is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ingrid S. Zeelenberg has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ingrid S. Zeelenberg's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (7 papers). Ingrid S. Zeelenberg is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (7 papers). Ingrid S. Zeelenberg collaborates with scholars based in Netherlands, France and Germany. Ingrid S. Zeelenberg's co-authors include Ed Roos, Sebastián Amigorena, Alexandre Boissonnas, Luc Fetler, Stéphanie Hugues, Carl G. Figdor, Clotilde Théry, Maaike A Van Hout-Kuijer, Paul J. Tacken and Luis J. Cruz and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Ingrid S. Zeelenberg

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid S. Zeelenberg Netherlands 13 903 684 573 193 120 19 1.5k
Michael Campoli United States 20 817 0.9× 620 0.9× 383 0.7× 78 0.4× 53 0.4× 24 1.3k
Katarzyna Franciszkiewicz France 12 1.2k 1.3× 980 1.4× 352 0.6× 170 0.9× 156 1.3× 14 1.8k
Ranjani Rajapaksa United States 17 1.3k 1.4× 807 1.2× 605 1.1× 87 0.5× 57 0.5× 23 1.9k
Itamar Goldstein Israel 25 911 1.0× 310 0.5× 608 1.1× 168 0.9× 79 0.7× 47 1.7k
Carmen Visús United States 16 607 0.7× 588 0.9× 740 1.3× 403 2.1× 104 0.9× 24 1.3k
Tomoaki Nakagawa Japan 10 445 0.5× 790 1.2× 565 1.0× 257 1.3× 140 1.2× 12 1.4k
Hélène Salmon France 12 974 1.1× 1.1k 1.6× 479 0.8× 256 1.3× 183 1.5× 20 1.8k
Siguo Hao China 25 764 0.8× 452 0.7× 1.1k 2.0× 457 2.4× 142 1.2× 62 1.7k
Cornelia Marty Switzerland 12 465 0.5× 284 0.4× 825 1.4× 88 0.5× 143 1.2× 12 1.3k
Christoph Uherek Germany 15 964 1.1× 873 1.3× 491 0.9× 53 0.3× 110 0.9× 22 1.6k

Countries citing papers authored by Ingrid S. Zeelenberg

Since Specialization
Citations

This map shows the geographic impact of Ingrid S. Zeelenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid S. Zeelenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid S. Zeelenberg more than expected).

Fields of papers citing papers by Ingrid S. Zeelenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid S. Zeelenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid S. Zeelenberg. The network helps show where Ingrid S. Zeelenberg may publish in the future.

Co-authorship network of co-authors of Ingrid S. Zeelenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid S. Zeelenberg. A scholar is included among the top collaborators of Ingrid S. Zeelenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid S. Zeelenberg. Ingrid S. Zeelenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kroesen, Michiel, Maaike A Van Hout-Kuijer, Ingrid S. Zeelenberg, et al.. (2015). Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents. Cancer Immunology Immunotherapy. 64(5). 563–572. 19 indexed citations
2.
Cruz, Luis J., Paul J. Tacken, Ingrid S. Zeelenberg, et al.. (2014). Tracking Targeted Bimodal Nanovaccines: Immune Responses and Routing in Cells, Tissue, and Whole Organism. Molecular Pharmaceutics. 11(12). 4299–4313. 44 indexed citations
3.
Zeelenberg, Ingrid S., Wendy W. C. van Maren, Alexandre Boissonnas, et al.. (2011). Antigen Localization Controls T Cell-Mediated Tumor Immunity. The Journal of Immunology. 187(3). 1281–1288. 32 indexed citations
4.
Tacken, Paul J., Ingrid S. Zeelenberg, Luis J. Cruz, et al.. (2011). Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood. 118(26). 6836–6844. 147 indexed citations
5.
Zeelenberg, Ingrid S., Matías Ostrowski, Sophie Krumeich, et al.. (2008). Targeting Tumor Antigens to Secreted Membrane Vesicles In vivo Induces Efficient Antitumor Immune Responses. Cancer Research. 68(4). 1228–1235. 237 indexed citations
6.
Théry, Clotilde, Matías Ostrowski, & Ingrid S. Zeelenberg. (2008). Des vésicules sécrétéesin vivopermettent d’améliorer la réponse immune anti-tumorale. médecine/sciences. 24(6-7). 581–583. 2 indexed citations
7.
Boissonnas, Alexandre, Luc Fetler, Ingrid S. Zeelenberg, Stéphanie Hugues, & Sebastián Amigorena. (2007). In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. The Journal of Experimental Medicine. 204(2). 345–356. 301 indexed citations
8.
Boissonnas, Alexandre, Luc Fetler, Ingrid S. Zeelenberg, Stéphanie Hugues, & Sebastián Amigorena. (2007). In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. The Journal of Cell Biology. 176(4). i8–i8. 6 indexed citations
9.
Meijer, Joost M., Ingrid S. Zeelenberg, Bence Sipos, & Ed Roos. (2006). The CXCR5 Chemokine Receptor Is Expressed by Carcinoma Cells and Promotes Growth of Colon Carcinoma in the Liver. Cancer Research. 66(19). 9576–9582. 79 indexed citations
10.
Zeelenberg, Ingrid S., et al.. (2006). Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration. Journal of Cell Science. 120(2). 219–228. 19 indexed citations
11.
Zeelenberg, Ingrid S.. (2004). Chemokine receptor signals: role in migration, invasion and cancer metastasis. UvA-DARE (University of Amsterdam). 1 indexed citations
12.
Zeelenberg, Ingrid S., et al.. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.. PubMed. 63(13). 3833–9. 378 indexed citations
13.
14.
Zeelenberg, Ingrid S., et al.. (2001). Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. Journal of Clinical Investigation. 108(2). 269–277. 45 indexed citations
15.
Zeelenberg, Ingrid S., et al.. (2001). Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. Journal of Clinical Investigation. 108(2). 269–277. 3 indexed citations
16.
Vugt, Martine J. van, et al.. (1999). The alternatively spliced CD64 transcript FcγRIb2 does not specify a surface‐expressed isoform. European Journal of Immunology. 29(1). 143–149. 19 indexed citations
17.
Vugt, Martine J. van, Monique J. Kleijmeer, Tibor Keler, et al.. (1999). The FcγRIa (CD64) Ligand Binding Chain Triggers Major Histocompatibility Complex Class II Antigen Presentation Independently of Its Associated FcR γ-Chain. Blood. 94(2). 808–817. 7 indexed citations
18.
Vugt, Martine J. van, Monique J. Kleijmeer, Tibor Keler, et al.. (1999). The FcγRIa (CD64) Ligand Binding Chain Triggers Major Histocompatibility Complex Class II Antigen Presentation Independently of Its Associated FcR γ-Chain. Blood. 94(2). 808–817. 74 indexed citations
19.
Vugt, Martine J. van, et al.. (1999). The alternatively spliced CD64 transcript FcγRIb2 does not specify a surface-expressed isoform. European Journal of Immunology. 29(1). 143–149. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026